It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cell lines are valuable resources as model for human biology and translational medicine. It is thus important to explore the concordance between the expression in various cell lines vis-à-vis human native and disease tissues. In this study, we investigate the expression of all human protein-coding genes in more than 1,000 human cell lines representing 27 cancer types by a genome-wide transcriptomics analysis. The cell line gene expression is compared with the corresponding profiles in various tissues, organs, single-cell types and cancers. Here, we present the expression for each cell line and give guidance for the most appropriate cell line for a given experimental study. In addition, we explore the cancer-related pathway and cytokine activity of the cell lines to aid human biology studies and drug development projects. All data are presented in an open access cell line section of the Human Protein Atlas to facilitate the exploration of all human protein-coding genes across these cell lines.
During preclinical drug development, the ability of cancer cell lines to faithfully model human disease is important for identifying potential therapeutic strategies. Here, using transcriptomic datasets of over 1000 cell lines, the authors evaluate how representative each line is of its cancer type and present their cell line selection tool.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details











1 KTH Royal Institute of Technology, Science for Life Laboratory, Department of Protein Science, Stockholm, Sweden (GRID:grid.5037.1) (ISNI:0000000121581746)
2 Atatürk University, Department of Medical Biology, Faculty of Medicine, Erzurum, Turkey (GRID:grid.411445.1) (ISNI:0000 0001 0775 759X)
3 KTH Royal Institute of Technology, Science for Life Laboratory, Department of Protein Science, Stockholm, Sweden (GRID:grid.5037.1) (ISNI:0000000121581746); Karolinska Institute, Department of Neuroscience, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
4 KTH Royal Institute of Technology, Science for Life Laboratory, Department of Protein Science, Stockholm, Sweden (GRID:grid.5037.1) (ISNI:0000000121581746); King’s College London, Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)